Does the Myriad Decision Presage a Golden Age of Patent-Free Personalized Medicine?
Patent Docs
By Kevin E. Noonan -- The Supreme Court's decision in the Myriad case has been almost universally hailed as being a great victory for patients, doctors, personalized medicine, and research. Precluding patenting for "merely" isolated human DNA, while permitting cDNA to be patent-eligible, is seen as being a rational compromise ("The Supreme Court got it exactly right," according to amicus Eric Lander of the Broad Institute) and no less a legal luminary than Nina Totenberg has said that the decision has "enormous implications for the future of personalized medicine and in many ways is likely to shape the future of...